| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 42.8983 | 17 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.8739 | 31 |
| GSM780709 | Untreated after 4 days (C3_1) | 40.4922 | 8 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.9087 | 36 |
| GSM780720 | Untreated after 4 days (C2_2) | 42.343 | 15 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.4679 | 29 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.9358 | 13 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.4782 | 20 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.024 | 22 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 39.4888 | 5 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.2011 | 33 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.4839 | 43 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.6398 | 25 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.7092 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.0741 | 41 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.8102 | 26 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.9939 | 41 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.3505 | 29 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.9313 | 36 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.0042 | 22 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.8608 | 41 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 41.6398 | 12 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.5708 | 25 |